Order results by:
| Issue | Title | |
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
| S. E. Belov, A. N. Boyko | ||
| "... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..." | ||
| Vol 10, No 4 (2018) | Environmental factors and a risk for multiple sclerosis in the Altai Territory | Abstract similar documents |
| I. P. Saldan, I. V. Smagina, S. A. Elchaninova | ||
| "... Multiple sclerosis (MS) is a chronic dysimmune neurodegenerative disease of the central nervous ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... More than 10 multiple sclerosis-modifying drugs (MSMDs) are widely used now. Novel MSMDs should ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
| E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
| "... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
| Vol 4, No 2 (2012) | Clinical characteristics of multiple sclerosis in the Tomsk region | Abstract similar documents |
| V M Alifirova, M A Titova | ||
| "... Two hundred and eighty patients (102 men and 178 women; mean age 38.8ё0.7 years) with multiple ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... Objective: to study the clinical and epidemiological features of multiple sclerosis (MS ..." | ||
| Vol 11, No 3 (2019) | Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko | ||
| "... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... give their own experience of its use in the Moscow Multiple Sclerosis Center. Objective: to assess ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... Owing to the advent of current methods for the prevention of exacerbations of multiple sclerosis ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Informative value of neuropsychological tests for multiple sclerosis | Abstract similar documents |
| A. R. Kabaeva, A. N. Boyko | ||
| "... Cognitive impairment (CI) occurs in 43–70% of patients with multiple sclerosis (MS) at both early ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... Multiple sclerosis (MS) is a demyelinating disease of the CNS, which affects mainly young able ..." | ||
| Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
| A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
| "... Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... Currently, special attention is paid to timely treatment for active forms of multiple sclerosis ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... in the pathogenesis of multiple sclerosis (MS). Objective: to analyze the association of BAFF gene polymorphisms (rs ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Rehabilitation of patients with multiple sclerosis in terms of evidence-based medicine: techniques for digitizing the results | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... the effectiveness of rehabilitation in patients with multiple sclerosis (MS). It is necessary to investigate ..." | ||
| Vol 6, No 2 (2014) | Predementia states and dementia in young people | Abstract similar documents |
| A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova | ||
| "... in patients with neuroAIDS, Huntington’s disease, or multiple sclerosis. ..." | ||
| Vol 12, No 3 (2020) | Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism | Abstract PDF (Eng) similar documents |
| I. V. Smagina, K. V. Lunev, S. A. Elchaninova | ||
| "... on the relationship of multiple sclerosis (MS) to vitamin D supplementation Objective: to assess the relationship ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
| Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
| "... risk of multiple sclerosis (MS). Objective: to analyze the frequency of mtDNA variants in patients ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..." | ||
| Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... Multiple sclerosis (MS)-related fatigue is encountered in 75–92% of patients and it is one ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
| Vol 7, No 1 (2015) | Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use | Abstract similar documents |
| I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova | ||
| "... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis | Abstract PDF (Eng) similar documents |
| M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..." | ||
| Vol 10, No 3 (2018) | Balo's concentric sclerosis: a clinical case | Abstract PDF (Eng) similar documents |
| I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin | ||
| "... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..." | ||
| Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
| T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
| Vol 12, No 3 (2020) | Anti-MOG associated myelitis | Abstract PDF (Eng) similar documents |
| A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko | ||
| "... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..." | ||
| 1 - 36 of 36 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
